Lobbying

Bioreference Laboratories An Opko Health Company's latest lobbying report covers Q4 2024, at $17K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Bioreference Laboratories An Opko Health Company

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Bioreference Laboratories An Opko Health Company lobbying by quarter
Bioreference Laboratories An Opko Health Company lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$25K1
Q2 2023$25K1
Q3 2023$25K1
Q4 2023$25K1
Q1 2024$25K1
Q2 2024$25K1
Q3 2024$25K1
Q4 2024$17K1
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$217K · 8 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • SENATE8 reports
  • HOUSE OF REPRESENTATIVES7 reports

Firms it paid

Firm
JD Liss Associates Formerly Known As Jonathan David Liss$242K9 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
25/01/06for Q4 2024JD Liss Associates Formerly Known As Jonathan David Liss$17K
24/10/31for Q3 2024JD Liss Associates Formerly Known As Jonathan David Liss$25K
24/07/30for Q2 2024JD Liss Associates Formerly Known As Jonathan David Liss$25K
24/04/04for Q1 2024JD Liss Associates Formerly Known As Jonathan David Liss$25K
24/02/05for Q4 2023JD Liss Associates Formerly Known As Jonathan David Liss$25K
23/10/02for Q3 2023JD Liss Associates Formerly Known As Jonathan David Liss$25K
23/08/04for Q2 2023JD Liss Associates Formerly Known As Jonathan David Liss$25K
23/04/21for Q1 2023JD Liss Associates Formerly Known As Jonathan David Liss$25K
23/01/08for Q4 2022JD Liss Associates Formerly Known As Jonathan David Liss$50K